Targeting the Cancer Biomarker CD47: A Review on the Diverse Mechanisms of the CD47 Pathway in Cancer Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|16|6|658-667

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.16, Iss.6, 2016-04, pp. : 658-667

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer

By  

Cancer Medicine, Vol. 4, Iss. 9, 2015-09 ,pp. : 1322-1333

John Wiley & Sons Inc

Access to resources Recommend Favorite

The role of CD44+/CD24-/low biomarker for screening, diagnosis and monitoring of breast cancer

By                  

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1127-1132

Spandidos Publications

Access to resources Recommend Favorite

Targeting CD83 for the treatment of graft-versus-host disease (Review)

By Wang Xiongfei   Wei Ming Q.   Liu Xiaosong  

Experimental and Therapeutic Medicine, Vol. 5, Iss. 6, 2013-06 ,pp. : 1545-1550

Spandidos Publications

Access to resources Recommend Favorite

An oncolytic herpes simplex virus vector, G47∆, synergizes with paclitaxel in the treatment of breast cancer

By            

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2355-2361

Spandidos Publications

Access to resources Recommend Favorite

Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma

By                        

International Journal of Oncology, Vol. 43, Iss. 6, 2013-01 ,pp. : 1855-1863

Spandidos Publications

Access to resources Recommend Favorite